{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:31:39Z","timestamp":1788208299388,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/gt.2015.70","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T14:52:37Z","timestamp":1437058357000},"page":"977-983","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Strategy of STAT3\u03b2 cell-specific expression in macrophages exhibits antitumor effects on mouse breast cancer"],"prefix":"10.1038","volume":"22","author":[{"given":"W","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,1]]},"reference":[{"key":"BFgt201570_CR1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA . Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19: 1423\u20131437.","journal-title":"Nat Med"},{"key":"BFgt201570_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tcb.2013.09.007","volume":"24","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Yang P, Wang XF . Microenvironmental regulation of cancer metastasis by miRNAs. Trends Cell Biol 2014; 24: 153\u2013160.","journal-title":"Trends Cell Biol"},{"key":"BFgt201570_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1373\/clinchem.2012.185363","volume":"59","author":"NE Sounni","year":"2013","unstructured":"Sounni NE, Noel A . Targeting the tumor microenvironment for cancer therapy. Clin Chem 2013; 59: 85\u201393.","journal-title":"Clin Chem"},{"key":"BFgt201570_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW . Macrophage biology in development, homeostasis and disease. Nature 2013; 496: 445\u2013455.","journal-title":"Nature"},{"key":"BFgt201570_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ccr.2013.02.013","volume":"23","author":"M De Palma","year":"2013","unstructured":"De Palma M, Lewis CE . Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013; 23: 277\u2013286.","journal-title":"Cancer Cell"},{"key":"BFgt201570_CR6","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/cancers6031670","volume":"6","author":"T Chanmee","year":"2014","unstructured":"Chanmee T, Ontong P, Konno K, Itano N . Tumor-associated macrophages as major players in the tumor microenvironment. Cancers 2014; 6: 1670\u20131690.","journal-title":"Cancers"},{"key":"BFgt201570_CR7","first-page":"838632","volume":"2014","author":"KF He","year":"2014","unstructured":"He KF, Zhang L, Huang CF, Ma SR, Wang YF, Wang WM et al. CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma. Biomed Res Int 2014; 2014: 838632.","journal-title":"Biomed Res Int"},{"key":"BFgt201570_CR8","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4049\/jimmunol.1103248","volume":"189","author":"XZ Ye","year":"2012","unstructured":"Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen L et al. Tumor-associated microglia\/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway. J Immunol 2012; 189: 444\u2013453.","journal-title":"J Immunol"},{"key":"BFgt201570_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccr.2014.03.021","volume":"25","author":"S Su","year":"2014","unstructured":"Su S, Liu Q, Chen J, Chen F, He C, Huang D et al. A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis. Cancer Cell 2014; 25: 605\u2013620.","journal-title":"Cancer Cell"},{"key":"BFgt201570_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","volume":"19","author":"J Chen","year":"2011","unstructured":"Chen J, Yao Y, Gong C, Yu F, Su S, Liu B et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 2011; 19: 541\u2013555.","journal-title":"Cancer Cell"},{"key":"BFgt201570_CR11","doi-asserted-by":"publisher","first-page":"7051","DOI":"10.18632\/oncotarget.2251","volume":"5","author":"NM Fofaria","year":"2014","unstructured":"Fofaria NM, Srivastava SK . Critical role of STAT3 in melanoma metastasis through anoikis resistance. Oncotarget 2014; 5: 7051\u20137064.","journal-title":"Oncotarget"},{"key":"BFgt201570_CR12","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R . STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9: 798\u2013809.","journal-title":"Nat Rev Cancer"},{"key":"BFgt201570_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nri1995","volume":"7","author":"H Yu","year":"2007","unstructured":"Yu H, Kortylewski M, Pardoll D . Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007; 7: 41\u201351.","journal-title":"Nat Rev Immunol"},{"key":"BFgt201570_CR14","doi-asserted-by":"publisher","first-page":"e65896","DOI":"10.1371\/journal.pone.0065896","volume":"8","author":"X Zhang","year":"2013","unstructured":"Zhang X, Tian W, Cai X, Wang X, Dang W, Tang H et al. Hydrazinocurcumin encapsuled nanoparticles \"re-educate\" tumor-associated macrophages and exhibit anti-tumor effects on breast cancer following STAT3 suppression. PLoS One 2013; 8: e65896.","journal-title":"PLoS One"},{"key":"BFgt201570_CR15","first-page":"348539","volume":"2014","author":"Y Fujiwara","year":"2014","unstructured":"Fujiwara Y, Takeya M, Komohara Y . A novel strategy for inducing the antitumor effects of triterpenoid compounds: blocking the protumoral functions of tumor-associated macrophages via STAT3 inhibition. Biomed Res Int 2014; 2014: 348539.","journal-title":"Biomed Res Int"},{"key":"BFgt201570_CR16","first-page":"3276","volume":"61","author":"G Niu","year":"2001","unstructured":"Niu G, Shain KH, Huang M, Ravi R, Bedi A, Dalton WS et al. Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Res 2001; 61: 3276\u20133280.","journal-title":"Cancer Res"},{"key":"BFgt201570_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/mmr_00000170","volume":"2","author":"G Xu","year":"2009","unstructured":"Xu G, Zhang C, Zhang J . Dominant negative STAT3 suppresses the growth and invasion capability of human lung cancer cells. Mol Med Rep 2009; 2: 819\u2013824.","journal-title":"Mol Med Rep"},{"key":"BFgt201570_CR18","doi-asserted-by":"publisher","first-page":"17779","DOI":"10.1073\/pnas.1108482108","volume":"108","author":"F Zammarchi","year":"2011","unstructured":"Zammarchi F, de Stanchina E, Bournazou E, Supakorndej T, Martires K, Riedel E et al. Antitumorigenic potential of STAT3 alternative splicing modulation. Proc Natl Acad Sci USA 2011; 108: 17779\u201317784.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt201570_CR19","doi-asserted-by":"publisher","first-page":"13221","DOI":"10.1074\/jbc.271.22.13221","volume":"271","author":"E Caldenhoven","year":"1996","unstructured":"Caldenhoven E, van Dijk TB, Solari R, Armstrong J, Raaijmakers JA, Lammers JW et al. STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem 1996; 271: 13221\u201313227.","journal-title":"J Biol Chem"},{"key":"BFgt201570_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/gt.2014.3","volume":"21","author":"WS Kang","year":"2014","unstructured":"Kang WS, Kwon JS, Kim HB, Jeong HY, Kang HJ, Jeong MH et al. A macrophage-specific synthetic promoter for therapeutic application of adiponectin. Gene Therapy 2014; 21: 353\u2013362.","journal-title":"Gene Therapy"},{"key":"BFgt201570_CR21","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/gt.2011.195","volume":"19","author":"MC Levin","year":"2012","unstructured":"Levin MC, Lidberg U, Jirholt P, Adiels M, Wramstedt A, Gustafsson K et al. Evaluation of macrophage-specific promoters using lentiviral delivery in mice. Gene Therapy 2012; 19: 1041\u20131047.","journal-title":"Gene Therapy"},{"key":"BFgt201570_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijantimicag.2009.04.014","volume":"34","author":"YA Wen","year":"2009","unstructured":"Wen YA, Yu XL, Xia QF, Cen D, Liu JB, Tu ZG . Macrophage-specific overexpression of antimicrobial peptide PR-39 inhibits intracellular growth of Salmonella enterica serovar Typhimurium in macrophage cells. Int J Antimicrob Agents 2009; 34: 315\u2013321.","journal-title":"Int J Antimicrob Agents"},{"key":"BFgt201570_CR23","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nprot.2007.135","volume":"2","author":"J Luo","year":"2007","unstructured":"Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2007; 2: 1236\u20131247.","journal-title":"Nat Protoc"},{"key":"BFgt201570_CR24","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1172\/JCI27648","volume":"116","author":"Y Luo","year":"2006","unstructured":"Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, Dolman C et al. Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 2006; 116: 2132\u20132141.","journal-title":"J Clin Invest"},{"key":"BFgt201570_CR25","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1158\/0008-5472.CAN-10-0736","volume":"70","author":"A Herrmann","year":"2010","unstructured":"Herrmann A, Kortylewski M, Kujawski M, Zhang C, Reckamp K, Armstrong B et al. Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells. Cancer Res 2010; 70: 7455\u20137464.","journal-title":"Cancer Res"},{"key":"BFgt201570_CR26","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.ccr.2012.03.039","volume":"21","author":"J Deng","year":"2012","unstructured":"Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C et al. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 2012; 21: 642\u2013654.","journal-title":"Cancer Cell"},{"key":"BFgt201570_CR27","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.1038\/sj.onc.1204990","volume":"20","author":"WM Burke","year":"2001","unstructured":"Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reynolds RK et al. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 2001; 20: 7925\u20137934.","journal-title":"Oncogene"},{"key":"BFgt201570_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1046\/j.1365-2567.2001.01256.x","volume":"103","author":"PJ Gough","year":"2001","unstructured":"Gough PJ, Gordon S, Greaves DR . The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo. Immunology 2001; 103: 351\u2013361.","journal-title":"Immunology"},{"key":"BFgt201570_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1089\/hum.2006.17.949","volume":"17","author":"W He","year":"2006","unstructured":"He W, Qiang M, Ma W, Valente AJ, Quinones MP, Wang W et al. Development of a synthetic promoter for macrophage gene therapy. Hum Gene Ther 2006; 17: 949\u2013959.","journal-title":"Hum Gene Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt201570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201570","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt201570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:37:00Z","timestamp":1648561020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt201570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,1]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFgt201570"],"URL":"https:\/\/doi.org\/10.1038\/gt.2015.70","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,1]]},"assertion":[{"value":"3 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}